Tuesday, November 5, 2024
HomeTagsAD

AD

First Subject Enrolled in Phase II/III Study of Eisai’s Alzheimer Antibody

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced that the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School...

Smart Meter Announces Partnership With A&D Medical

Smart Meter, the leader in cellular-enabled remote patient monitoring (RPM) data and devices, announced a partnership with A&D Medical, a global leader in connected...

LeddarTech to Showcase Critical Sensing and Perception Solutions Enabling ADAS and Autonomous Driving at CES Las Vegas 2022

LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce its participation at...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics